The University of Nottingham and I Holland collaborate in Anti-Stick Research
29 March 2012 | By I Holland Ltd
I Holland are delighted to announce the launch of a two year TSAR project...
List view / Grid view
News
BASF aligns research even more closely to future topics, global markets and customer industries
29 March 2012 | By BASF
BASF is setting itself ambitious goals...
Roche raises offer for Illumina to over $6bn
29 March 2012 | By Roche
Roche increases offer price for gene sequencing firm Illumina to US$ 51.00 per share...
Lundbeck awarded for ethical leadership in the pharmaceutical industry
29 March 2012 | By H. Lundbeck A/S
Lundbeck is becoming the first recipient of a new award for ethical leadership in the pharmaceutical industry...
Gerresheimer at the PDA Parenteral Packaging Conference in Phoenix Arizona
28 March 2012 | By Gerresheimer AG
Gerresheimer will display its comprehensive range of tubular glass...
Agreement to develop diagnostic assays for Alzheimer’s disease
28 March 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Meso Scale Discovery have entered an agreement...
Merck provides update on IMPROVE-IT Trial
28 March 2012 | By Merck
The DSMB of the IMPROVE-IT trial has completed the second pre-specified interim efficacy analysis of the study...
Merck appoints Michael J. Holston as Chief Ethics and Compliance Officer
28 March 2012 | By Merck
Long-time Merck and Schering-Plough Executive Richard S. Bowles to retire...
Novartis launches the CCLE to catalogue world’s cancer cell lines
28 March 2012 | By Novartis
Collaboration with the Broad Institute yields comprehensive encyclopedia of genetic and molecular information...
Novasep opens new 2,000 m2 expanded Shanghai facilities to meet increasing East Asia demand
27 March 2012 | By Andrew Lloyd & Associates
Novasep announces the opening of a new 2,000 m2 facility in Shanghai Pudong district...
Biomarker specialist Activiomics appoints Dr Trevor Nicholls as Non-Executive Chairman
27 March 2012 | By College Hill
Activiomics Limited., the developer of innovative biomarker technologies has announced the appointment of industry leader Dr Trevor Nicholls to its Board as Non-Executive Chairman.
US court denies preliminary injunction application against the FDA
26 March 2012 | By AstraZeneca
The US District Court for the District of Columbia issued an opinion and order in AstraZeneca’s lawsuit...
Sanofi and Regeneron report Phase 2 data for potential first-in-class lipid-lowering PCSK9 antibody
26 March 2012 | By Sanofi
Data from two Phase 2 trials announced...
Teva announces FDA approval of QNASLTM
26 March 2012 | By Teva Pharmaceutical Industries Ltd
New treatment with “dry” mode of delivery seeks to address unmet needs of seasonal and perennial allergy sufferers...
Amgen’s PCSK9 Inhibitor reduced LDL cholesterol up to 81 percent in Phase 1b study
25 March 2012 | By Amgen
Robust AMG 145 Phase 2 program expected to deliver results in 2012...
